Dr Melinda F Evans, MD | |
1606 23rd Ave, Fairbanks, AK 99701-6407 | |
(907) 455-4567 | |
(907) 458-1581 |
Full Name | Dr Melinda F Evans |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Location | 1606 23rd Ave, Fairbanks, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083620918 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 2208 (Alaska) | Primary |
207R00000X | Internal Medicine | 2208 (Alaska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Melinda F Evans, MD 1606 23rd Ave, Fairbanks, AK 99701-6407 Ph: (907) 455-4567 | Dr Melinda F Evans, MD 1606 23rd Ave, Fairbanks, AK 99701-6407 Ph: (907) 455-4567 |
News Archive
The benefits of computed tomography (CT) have increased greatly over the past decade. Now twice as powerful, it offers dynamic images of anatomy, including the beating heart. Future advancements promise to deliver even more clinical benefits. However, CT has always had a downside: it can deliver high radiation doses to patients, putting them at increased risk of developing cancer.
Surgically repairing a painful shoulder injury in baseball players known as a SLAP tear (superior labral) varies widely and often doesn't allow for return to play at the same level as before the injury. However, researchers presenting their findings at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Baltimore, Maryland suggest that nonsurgical treatment may be more beneficial.
The UK will be transformed into a global hub for radiotherapy research, pioneering the use of the latest techniques such as FLASH radiotherapy and artificial intelligence, with a new £56 million research network announced by Cancer Research UK today (Monday).
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today reported positive preliminary results from a Phase Ib clinical trial to evaluate the safety and efficacy of MN-221 in patients with stable, moderate to severe chronic obstructive pulmonary disease (COPD). There were no clinically significant safety concerns noted. Preliminary results demonstrated clinically significant improvements in percent change in forced expiratory volume in one second (FEV(1)).
› Verified 1 days ago
Dr. James W Cagle Jr., D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Suite 280 Nt, Fairbanks, AK 99701 Phone: 907-458-5178 Fax: 907-458-5180 | |
Jeffrey A Partnow, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 907-458-5178 Fax: 907-458-5180 | |
Dr. Arva Yahua Chiu, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1626 30th Ave, Fairbanks, AK 99701 Phone: 907-452-2637 Fax: 877-410-0865 | |
Keith B. Gianni, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1222 Well St, Suite One, Fairbanks, AK 99701 Phone: 907-452-6137 Fax: 907-452-6139 | |
David M Stieber, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1626 30th Avenue Ste 204, Fairbanks, AK 99701 Phone: 907-374-0432 Fax: 907-374-9932 | |
Dr. Daniel Kechker, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Hospitalists Office, Fairbanks, AK 99701 Phone: 907-458-5178 Fax: 907-458-5180 | |
Dr. Romel C Wrenn, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 907-458-6450 Fax: 907-458-6430 |